Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 27.3647.7027.698.479.60

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 27.36 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202527.36
Mar202447.70
Mar202327.69
Mar20228.47
Mar20219.60

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 27.36
-42.64
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47
-11.77
Mar2021 9.6 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,864.9 Cr 0.6% -7.2% 33.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,036.0 Cr 0.8% -4.2% 7% Stock Analytics
DIVIS LABORATORIES ₹178,218.0 Cr 1.1% -0.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,099.0 Cr 0% 1.3% 40.1% Stock Analytics
CIPLA ₹110,897.0 Cr -0.3% -4.1% -8.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,591.0 Cr 0.4% -4.5% -5.2% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.6%

-7.2%

33.4%

SENSEX

3.9%

1.9%

-6.8%


You may also like the below Video Courses